Tekla Life Sciences Investors (HQL) Revenue & EPS Growth Rates 2026

Growth Analysis - HQL

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth-0.35%

5Y CAGR-6.99%

10Y CAGR51.88%

Net Income

1Y Growth0.35%

5Y CAGR-7.00%

10Y CAGR7.77%

EPS

1Y Growth-2.63%

5Y CAGR-10.52%

10Y CAGR3.69%

EBIT

1Y GrowthN/A

5Y CAGR-7.00%

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGR-7.00%

10Y CAGRN/A

Capex

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Equity

1Y Growth11.74%

5Y CAGR1.21%

10Y CAGR1.05%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Sep 30, 2025	-0.3%	91.6%	N/A	-7.0%	51.9%	29.3%	25.7%	N/A
FY 2024 Sep 30, 2024	268.5%	N/A	9.7%	104.2%	58.3%	41.8%	32.3%	N/A
FY 2023 Sep 30, 2023	N/A	-40.2%	-42.6%	64.0%	46.5%	19.3%	20.0%	N/A
FY 2022 Sep 30, 2022	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Sep 30, 2021	-47.1%	418.8%	221.0%	59.9%	60.8%	25.0%	19.8%	N/A
FY 2020 Sep 30, 2020	4984.1%	690.5%	21.1%	148.0%	52.5%	39.0%	40.4%	N/A
FY 2019 Sep 30, 2019	22.9%	-81.3%	-27.1%	22.7%	18.2%	14.5%	10.7%	N/A
FY 2018 Sep 30, 2018	-97.2%	-43.8%	14.5%	30.9%	1.7%	8.2%	8.1%	N/A
FY 2017 Sep 30, 2017	1009.6%	626.5%	330.2%	100.7%	37.5%	33.3%	N/A	N/A
FY 2016 Sep 30, 2016	375.7%	167.9%	130.0%	61.6%	10.6%	8.8%	N/A	N/A
FY 2015 Sep 30, 2015	50.8%	60.0%	-14.9%	-6.2%	4.0%	16.2%	N/A	N/A
FY 2014 Sep 30, 2014	69.7%	-36.1%	15.4%	13.8%	10.6%	7.0%	N/A	N/A
FY 2013 Sep 30, 2013	-75.9%	-4.8%	-34.3%	-20.9%	-1.6%	1.4%	N/A	N/A
FY 2012 Sep 30, 2012	276.2%	8.5%	67.1%	-5.7%	8.6%	N/A	N/A	N/A
FY 2011 Sep 30, 2011	-68.7%	11.3%	-30.1%	-24.3%	-10.7%	N/A	N/A	N/A
FY 2010 Sep 30, 2010	295.7%	4.4%	-14.2%	15.4%	29.2%	N/A	N/A	N/A
FY 2009 Sep 30, 2009	-72.5%	-60.0%	-41.5%	7.5%	3.7%	N/A	N/A	N/A
FY 2008 Sep 30, 2008	-42.0%	-14.8%	23.3%	22.3%	14.8%	N/A	N/A	N/A
FY 2007 Sep 30, 2007	25.2%	79.9%	108.0%	25.1%	N/A	N/A	N/A	N/A
FY 2006 Sep 30, 2006	158.4%	168.1%	55.6%	5.4%	N/A	N/A	N/A	N/A
FY 2005 Sep 30, 2005	178.1%	20.8%	-1.8%	44.8%	N/A	N/A	N/A	N/A
FY 2004 Sep 30, 2004	-47.5%	-41.7%	-43.5%	0.0%	N/A	N/A	N/A	N/A
FY 2003 Sep 30, 2003	-35.1%	-41.3%	63.3%	7.7%	N/A	N/A	N/A	N/A
FY 2002 Sep 30, 2002	-46.9%	159.1%	43.2%	N/A	N/A	N/A	N/A	N/A
FY 2001 Sep 30, 2001	1164.3%	135.2%	61.5%	N/A	N/A	N/A	N/A	N/A
FY 1998 Sep 30, 1998	-56.3%	-42.3%	N/A	N/A	N/A	N/A	N/A	N/A
FY 1997 Sep 30, 1997	-23.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1996 Sep 30, 1996	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - HQL

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth-0.35%

5Y CAGR-6.99%

10Y CAGR51.88%

Net Income

1Y Growth0.35%

5Y CAGR-7.00%

10Y CAGR7.77%

EPS

1Y Growth-2.63%

5Y CAGR-10.52%

10Y CAGR3.69%

EBIT

1Y GrowthN/A

5Y CAGR-7.00%

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGR-7.00%

10Y CAGRN/A

Capex

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Equity

1Y Growth11.74%

5Y CAGR1.21%

10Y CAGR1.05%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Sep 30, 2025	-0.3%	91.6%	N/A	-7.0%	51.9%	29.3%	25.7%	N/A
FY 2024 Sep 30, 2024	268.5%	N/A	9.7%	104.2%	58.3%	41.8%	32.3%	N/A
FY 2023 Sep 30, 2023	N/A	-40.2%	-42.6%	64.0%	46.5%	19.3%	20.0%	N/A
FY 2022 Sep 30, 2022	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Sep 30, 2021	-47.1%	418.8%	221.0%	59.9%	60.8%	25.0%	19.8%	N/A
FY 2020 Sep 30, 2020	4984.1%	690.5%	21.1%	148.0%	52.5%	39.0%	40.4%	N/A
FY 2019 Sep 30, 2019	22.9%	-81.3%	-27.1%	22.7%	18.2%	14.5%	10.7%	N/A
FY 2018 Sep 30, 2018	-97.2%	-43.8%	14.5%	30.9%	1.7%	8.2%	8.1%	N/A
FY 2017 Sep 30, 2017	1009.6%	626.5%	330.2%	100.7%	37.5%	33.3%	N/A	N/A
FY 2016 Sep 30, 2016	375.7%	167.9%	130.0%	61.6%	10.6%	8.8%	N/A	N/A
FY 2015 Sep 30, 2015	50.8%	60.0%	-14.9%	-6.2%	4.0%	16.2%	N/A	N/A
FY 2014 Sep 30, 2014	69.7%	-36.1%	15.4%	13.8%	10.6%	7.0%	N/A	N/A
FY 2013 Sep 30, 2013	-75.9%	-4.8%	-34.3%	-20.9%	-1.6%	1.4%	N/A	N/A
FY 2012 Sep 30, 2012	276.2%	8.5%	67.1%	-5.7%	8.6%	N/A	N/A	N/A
FY 2011 Sep 30, 2011	-68.7%	11.3%	-30.1%	-24.3%	-10.7%	N/A	N/A	N/A
FY 2010 Sep 30, 2010	295.7%	4.4%	-14.2%	15.4%	29.2%	N/A	N/A	N/A
FY 2009 Sep 30, 2009	-72.5%	-60.0%	-41.5%	7.5%	3.7%	N/A	N/A	N/A
FY 2008 Sep 30, 2008	-42.0%	-14.8%	23.3%	22.3%	14.8%	N/A	N/A	N/A
FY 2007 Sep 30, 2007	25.2%	79.9%	108.0%	25.1%	N/A	N/A	N/A	N/A
FY 2006 Sep 30, 2006	158.4%	168.1%	55.6%	5.4%	N/A	N/A	N/A	N/A
FY 2005 Sep 30, 2005	178.1%	20.8%	-1.8%	44.8%	N/A	N/A	N/A	N/A
FY 2004 Sep 30, 2004	-47.5%	-41.7%	-43.5%	0.0%	N/A	N/A	N/A	N/A
FY 2003 Sep 30, 2003	-35.1%	-41.3%	63.3%	7.7%	N/A	N/A	N/A	N/A
FY 2002 Sep 30, 2002	-46.9%	159.1%	43.2%	N/A	N/A	N/A	N/A	N/A
FY 2001 Sep 30, 2001	1164.3%	135.2%	61.5%	N/A	N/A	N/A	N/A	N/A
FY 1998 Sep 30, 1998	-56.3%	-42.3%	N/A	N/A	N/A	N/A	N/A	N/A
FY 1997 Sep 30, 1997	-23.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1996 Sep 30, 1996	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - HQL

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Tekla Life Sciences Investors

Compare with peers

Explore

Growth Analysis - HQL

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Tekla Life Sciences Investors

Compare with peers

Explore